| Price | 8.60p on 06-04-2026 at 04:45:16 |
|---|---|
| Change | 0.00p 0% |
| Buy | 8.70p |
| Sell | 8.50p |
| Last Trade: | Buy 5,745.00 at 8.675p |
| Day's Volume: | 0 |
| Last Close: | 8.60p |
| Open: | 0.00p |
| ISIN: | GB00BYV81293 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £91.85m |
| VWAP: | 0.00p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 5,745 | 8.675p | Ordinary |
16:06:45 - 02-Apr-26 |
| Buy* | 20,000 | 8.634p | Ordinary |
15:58:03 - 02-Apr-26 |
| Buy* | 40,000 | 8.607p | Ordinary |
15:45:32 - 02-Apr-26 |
| Buy* | 150,000 | 8.55p | Ordinary |
15:43:45 - 02-Apr-26 |
| Buy* | 29,201 | 8.5475p | Ordinary |
15:38:06 - 02-Apr-26 |
| Sell* | 110 | 8.40p | SI Trade |
15:27:03 - 02-Apr-26 |
| Buy* | 16 | 8.60p | SI Trade |
15:27:03 - 02-Apr-26 |
| Buy* | 136 | 8.60p | SI Trade |
15:27:03 - 02-Apr-26 |
| Buy* | 69,919 | 8.56p | Ordinary |
15:26:44 - 02-Apr-26 |
| Buy* | 3,294 | 8.56p | Ordinary |
15:11:36 - 02-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
| 2nd Jan 2026 11:06 am | RNS | Block listing 6 Monthly Return |
